Prime Capital Investment Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Prime Capital Investment Advisors's RMD Position: Q2 2026 in Review
Prime Capital Investment Advisors reduced its ResMed (RMD) stake by 17% in Q2 2026, selling an estimated $595K and leaving 14,292 shares worth $2.79M. The position accounts for 0.03% of the portfolio, ranked #325.
Prime Capital Investment Advisors first reported a position in RMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.38M in Q1 2023. 605 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Prime Capital Investment Advisors held 14,292 shares of ResMed worth $2.79M as of Q2 2026.
- Prime Capital Investment Advisors sold 2,871 ResMed shares in Q2 2026, an estimated $595K.
- ResMed made up 0.03% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #325 holding.
- Prime Capital Investment Advisors first reported a position in ResMed in Q1 2023 and has held it in 14 quarters since.
- Prime Capital Investment Advisors's ResMed position peaked at $5.38M in Q1 2023.
- 605 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.